优化心房颤动患者的卒中与出血风险评估：证据、实用性与精准性的平衡 - Suppr

Suppr

超能文献

Optimizing Stroke and Bleeding Risk Assessment in Patients with Atrial Fibrillation: A Balance of Evidence, Practicality and Precision.

作者信息

Proietti Marco, Mujovic Nebojsa, Potpara Tatjana S

机构信息

Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, Milan, Italy.

Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy.

出版信息

Thromb Haemost. 2018 Dec;118(12):2014-2017. doi: 10.1055/s-0038-1676074. Epub 2018 Nov 20.

DOI:10.1055/s-0038-1676074

PMID:30458556

Abstract

摘要

相似文献

Optimizing Stroke and Bleeding Risk Assessment in Patients with Atrial Fibrillation: A Balance of Evidence, Practicality and Precision.优化心房颤动患者的卒中与出血风险评估：证据、实用性与精准性的平衡

Thromb Haemost. 2018 Dec;118(12):2014-2017. doi: 10.1055/s-0038-1676074. Epub 2018 Nov 20.

Patient's values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation.心房颤动患者预防卒中的价值观和偏好：通过口服抗凝平衡卒中和出血风险

Thromb Haemost. 2014 Mar 3;111(3):381-3. doi: 10.1160/TH14-01-0063. Epub 2014 Jan 30.

Underuse of Oral Anticoagulants for Nonvalvular Atrial Fibrillation: Past, Present, and Future.非瓣膜性心房颤动口服抗凝剂的使用不足：过去、现在与未来

Tex Heart Inst J. 2016 Aug 1;43(4):287-90. doi: 10.14503/THIJ-16-5785. eCollection 2016 Aug.

Long-term stroke and bleeding risk in patients with atrial fibrillation treated with oral anticoagulants in contemporary practice: Providing evidence for shared decision-making.在当代实践中，使用口服抗凝剂治疗的心房颤动患者的长期卒中与出血风险：为共同决策提供证据。

Int J Cardiol. 2017 Oct 15;245:174-177. doi: 10.1016/j.ijcard.2017.07.043. Epub 2017 Jul 14.

How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).医生的风险评估对心房颤动患者中风和出血的预测效果如何？来自心房颤动更明智治疗结果登记处（ORBIT-AF）的结果。

Am Heart J. 2016 Nov;181:145-152. doi: 10.1016/j.ahj.2016.07.026. Epub 2016 Aug 27.

Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice. A propensity-matched analysis of 76,940 patients.非瓣膜性心房颤动患者真实世界临床实践中阿哌沙班与华法林的有效性和安全性：76940 例患者的倾向性匹配分析。

Thromb Haemost. 2017 Jun 2;117(6):1072-1082. doi: 10.1160/TH17-01-0068. Epub 2017 Mar 16.

Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants.正在服用口服抗凝剂的房颤患者的出血风险评估

Hosp Pract (1995). 2013 Feb;41(1):71-8. doi: 10.3810/hp.2013.02.1012.

Challenges and Treatment for Stroke Prophylaxis in Patients with Atrial Fibrillation in Mexico: A Review.墨西哥心房颤动患者卒中预防的挑战与治疗：综述

Am J Cardiovasc Drugs. 2016 Jun;16(3):171-82. doi: 10.1007/s40256-016-0163-6.

[HAS-BLED shows bleeding risk in ischemic stroke and atrial fibrillation. But adjustments are needed for safer assessment, according to quality study].

Lakartidningen. 2012;109(38):1670-2.

Anticoagulation strategies for the management of postoperative atrial fibrillation.用于术后房颤管理的抗凝策略。

Clin Lab Med. 2014 Sep;34(3):537-61. doi: 10.1016/j.cll.2014.06.012. Epub 2014 Jul 19.

引用本文的文献

Validation of the CHA2DS2-VA Score (Excluding Female Sex) in Nonvalvular Atrial Fibrillation Patients: A Nationwide Population-Based Study.非瓣膜性心房颤动患者CHA2DS2-VA评分（不包括女性性别）的验证：一项基于全国人群的研究。

J Clin Med. 2022 Mar 25;11(7):1823. doi: 10.3390/jcm11071823.

Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society.心房颤动和静脉血栓栓塞症的出血风险评估与管理：ESC 血栓形成工作组联合欧洲心律协会、急性心血管护理协会和亚太心律学会共同制定的立场文件。

Europace. 2022 Nov 22;24(11):1844-1871. doi: 10.1093/europace/euac020.

Incidence and Predictors of Infections and All-Cause Death in Patients with Cardiac Implantable Electronic Devices: The Italian Nationwide RI-AIAC Registry.心脏植入式电子设备患者感染及全因死亡的发生率和预测因素：意大利全国性RI-AIAC注册研究

J Pers Med. 2022 Jan 11;12(1):91. doi: 10.3390/jpm12010091.

Risk prediction of clinical adverse outcomes with machine learning in a cohort of critically ill patients with atrial fibrillation.机器学习在伴有房颤的危重病患者队列中预测临床不良结局的风险。

Sci Rep. 2021 Sep 23;11(1):18925. doi: 10.1038/s41598-021-97218-2.

Combination of Oral Anticoagulants and Single Antiplatelets versus Triple Therapy in Nonvalvular Atrial Fibrillation and Acute Coronary Syndrome: Stroke Prevention among Asians.非瓣膜性心房颤动合并急性冠状动脉综合征患者中口服抗凝剂与单一抗血小板药物联合治疗对比三联疗法：亚洲人群的卒中预防

Int J Angiol. 2020 Jun;29(2):88-97. doi: 10.1055/s-0040-1708477. Epub 2020 May 6.

Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.颅内出血史的房颤患者中，华法林与非维生素 K 拮抗剂口服抗凝剂使用与缺血性卒、大出血和其他不良事件的关联。

JAMA Netw Open. 2020 Jun 1;3(6):e206424. doi: 10.1001/jamanetworkopen.2020.6424.

Comprehensive Management With the ABC (Atrial Fibrillation Better Care) Pathway in Clinically Complex Patients With Atrial Fibrillation: A Post Hoc Ancillary Analysis From the AFFIRM Trial.伴有临床复杂性房颤患者的 ABC（房颤更好护理）路径的综合管理：来自 AFFIRM 试验的事后辅助分析。

J Am Heart Assoc. 2020 May 18;9(10):e014932. doi: 10.1161/JAHA.119.014932. Epub 2020 May 6.

Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals.通过单次筛查检测到的心房颤动的估计中风风险、检出率和筛查所需人数：对 141220 名筛查个体的多国患者水平荟萃分析。

PLoS Med. 2019 Sep 25;16(9):e1002903. doi: 10.1371/journal.pmed.1002903. eCollection 2019 Sep.

Atrial Fibrillation in Older People: Concepts and Controversies.老年人的心房颤动：概念与争议

Front Med (Lausanne). 2019 Aug 8;6:175. doi: 10.3389/fmed.2019.00175. eCollection 2019.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验